Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viviane Callier

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responsesCamila D Odio, Rosemary A Aogo, Saba Firdous, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Lancet (London, England)|April 26, 2026
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trialLaura C Steinhardt, Titus K Kwambai, Martina Oneko, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comparison of Four Assays That Measure Antibodies to Ebola Virus GlycoproteinIrina Maljkovic Berry, Safaa Ben Farhat, Viviane Callier, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular VaccinesBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Iscience|April 20, 2026
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testingBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
The Journal of Infectious Diseases|February 18, 2026
Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMOAndrew P Platt, Viviane Callier, Alison Grazioli, et al.
Science Advances|October 12, 2023
Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficienciesMackenzie Zendt, Fausto A Bustos Carrillo, Sophie Kelly, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responsesCamila D Odio, Rosemary A Aogo, Saba Firdous, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Lancet (London, England)|April 26, 2026
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trialLaura C Steinhardt, Titus K Kwambai, Martina Oneko, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comparison of Four Assays That Measure Antibodies to Ebola Virus GlycoproteinIrina Maljkovic Berry, Safaa Ben Farhat, Viviane Callier, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular VaccinesBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Iscience|April 20, 2026
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testingBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
The Journal of Infectious Diseases|February 18, 2026
Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMOAndrew P Platt, Viviane Callier, Alison Grazioli, et al.
Science Advances|October 12, 2023
Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficienciesMackenzie Zendt, Fausto A Bustos Carrillo, Sophie Kelly, et al.
Pageof 4